Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone replacement in young male cancer survivors
ISRCTN70274195Phase 3Completed
- Sponsor
- Sheffield Teaching Hospitals NHS Foundation Trust
- Start
- Jul 2011
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of AndroForte and Placebo-COD Research Private Ltd in Hypoandrogenism (TD) (2 arms), sponsored by Sheffield Teaching Hospitals NHS Foundation Trust. Primary endpoints: Body composition and Physical function. Started Jul 2011; status: completed.
02
Drugs
AndroFortePlacebo-COD Research Private Ltd
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on ISRCTN70274195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN70274195.